KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Current Deferred Revenue (2017 - 2025)

Historic Current Deferred Revenue for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $376.0 million.

  • Elanco Animal Health's Current Deferred Revenue rose 1291.29% to $376.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $376.0 million, marking a year-over-year increase of 1291.29%. This contributed to the annual value of $332.0 million for FY2024, which is 953.68% down from last year.
  • Elanco Animal Health's Current Deferred Revenue amounted to $376.0 million in Q3 2025, which was up 1291.29% from $367.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Current Deferred Revenue registered a high of $376.0 million during Q3 2025, and its lowest value of $284.0 million during Q2 2022.
  • Over the past 5 years, Elanco Animal Health's median Current Deferred Revenue value was $329.0 million (recorded in 2023), while the average stood at $329.2 million.
  • In the last 5 years, Elanco Animal Health's Current Deferred Revenue surged by 10817.61% in 2021 and then plummeted by 1087.61% in 2022.
  • Elanco Animal Health's Current Deferred Revenue (Quarter) stood at $319.0 million in 2021, then increased by 1.57% to $324.0 million in 2022, then rose by 13.27% to $367.0 million in 2023, then decreased by 9.54% to $332.0 million in 2024, then increased by 13.25% to $376.0 million in 2025.
  • Its last three reported values are $376.0 million in Q3 2025, $367.0 million for Q2 2025, and $319.0 million during Q1 2025.